Resistance of escherichia coli to rifampicin and sorangicin A — A comparison

22Citations
Citations of this article
17Readers
Mendeley users who have this article in their library.

Abstract

Sorangicin A, a macrolide polyether antibiotic and the ansamycin antibiotic rifampicin inhibit DNA-dependent RNA polymerase to a similar extent. Resistance to sorangicin A is due to a mutation in the RNA polymerase which renders the enzyme less sensitive. Parallel investigations with rifampicin revealed partial cross-resistance, which was more marked in sorangicin A-resistant mutants than in rifampicin-resistant mutants. © 1990, JAPAN ANTIBIOTICS RESEARCH ASSOCIATION. All rights reserved.

Cite

CITATION STYLE

APA

Römmele, G., Wirz, G., Solf, R., Vosbeck, K., Gruner, J., & Wehrli, W. (1990). Resistance of escherichia coli to rifampicin and sorangicin A — A comparison. The Journal of Antibiotics, 43(1), 88–91. https://doi.org/10.7164/antibiotics.43.88

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free